查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813946

雇主和職場藥物檢測市場規模、佔有率和趨勢分析報告：按類型、產品、模式、藥物、最終用途、地區和細分市場預測，2025 年至 2033 年

Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment drug screens, Post-employment), By Product (Consumables), By Mode, By Drug, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

雇主和職場藥物檢測市場摘要

2024 年全球雇主和職場藥物測試市場價值估計為 61.051 億美元，預計到 2033 年將達到 90.899 億美元，2025 年至 2033 年的複合年成長率為 4.6%。

該市場專注於檢測生物樣本中非法和管制藥物的存在，以支持職場安全、法規遵循和生產力。

尿液、唾液、頭髮和血液分析等檢測方法廣泛應用於運輸、製造、建築和能源等行業，以減少職場事故和缺勤。雇主和職場的藥物檢測在入職前篩檢、隨機檢測和事後調查中發揮著至關重要的作用，有助於企業維護安全合規的員工隊伍。更嚴格的政府法規、倡導無毒環境的企業政策以及先進的快速檢測套組和實驗室確認方法的普及推動了藥物檢測的需求。人們日益意識到藥物濫用對員工績效和安全的影響，這進一步推動了已開發市場和新興市場的藥物檢測應用。

根據美國成癮中心的一項全國性調查，到2024年，15.3%的美國勞工將報告在工作中受到酒精影響，2.9%的勞動者將承認受到非法藥物的影響。這些數據對美國雇主構成了重大挑戰，並凸顯了製定強力的職場藥物檢測政策的必要性。此外，對職場安全和生產力的日益重視，正促使各組織採取措施，確保無毒環境。人們日益意識到職場藥物濫用的負面影響，包括生產力下降、缺勤率上升、工傷和法律責任，這進一步推動了對藥物檢測服務的需求。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 全球雇主和職場藥物測試市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場前景。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
  • 全球雇主和職場藥物測試市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章全球雇主和職場藥物測試市場：類型估計和趨勢分析

  • 細分儀表板
  • 全球雇主和職場藥物檢測市場波動分析
  • 全球雇主和職場藥物檢測市場規模和趨勢分析（按類型）（2021-2033）
  • 就業前藥物測試
  • 就業後

5. 全球雇主和職場藥物檢測市場：產品估計和趨勢分析

  • 細分儀表板
  • 全球雇主和職場藥物測試市場產品變化分析
  • 全球雇主和職場藥物檢測市場規模和趨勢分析（按產品，2021-2033 年）
  • 耗材
  • 裝置
  • 快速檢測裝置
  • 服務

6. 全球雇主和職場藥物測試市場：模式估計和趨勢分析

  • 細分儀表板
  • 全球雇主和職場藥物檢測市場波動分析
  • 全球雇主和職場藥物檢測市場規模和趨勢分析（按模式）（2021-2033）
  • 尿
  • 頭髮
  • 口腔液體
  • 即時測試

7. 全球雇主和職場藥物檢測市場：藥物估計和趨勢分析

  • 細分儀表板
  • 全球雇主和職場藥物測試市場的藥物變異分析
    • 全球雇主和職場藥物檢測市場規模和趨勢分析（按藥物，2021-2033 年）
  • 酒精
  • 大麻/大麻
  • 古柯鹼
  • 鴉片類藥物
  • 安非他命和甲基安非他命
  • LSD
  • 其他

8. 全球雇主和職場藥物測試市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 全球雇主和職場藥物測試市場最終用途變化分析
    • 2021 年至 2033 年全球雇主及職場藥物檢測市場規模及趨勢分析（依最終用途）
  • IT/金融
  • 製造業
  • 運輸
  • 建造
  • 零售和酒店
  • 衛生保健
  • 教育
  • 其他專業服務

9. 雇主和職場藥物檢測市場：區域估計和趨勢分析

  • 區域儀表板
  • 市場規模、預測趨勢分析，2021-2033年：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年公司市佔率分析
  • 主要認證提供者/計畫所有者列表
  • 公司簡介/上市公司
    • First Advantage
    • Laboratory Corporation of America Holdings（Labcorp）
    • Dragerwerk AG &Co. KGaA
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • Clinical Reference Laboratory Inc.
    • Quest Diagnostics
    • Cordant Health Solutions
    • DISA Global Solutions
    • HireRight, LLC
    • OraSure Technologies, Inc.
    • Psychemedics Corporation
    • Omega Laboratories
Product Code: GVR-4-68040-463-5

Employer And Workplace Drug Testing Market Summary

The global employer and workplace drug testing market size was estimated at USD 6,105.1 million in 2024 and is projected to reach 9,089.9 million by 2033, growing at a CAGR of 4.6% from 2025 to 2033. This market focuses on detecting the presence of illicit drugs and controlled substances in biological samples to support workplace safety, regulatory compliance, and productivity.

Testing methods such as urine, oral fluid, hair, and blood analysis are widely used across industries, including transportation, manufacturing, construction, and energy, to reduce workplace accidents and absenteeism. Employer and workplace drug testing plays a significant role in pre-employment screening, random testing, and post-incident investigations, helping organizations maintain a safe and compliant workforce. The demand is driven by stricter government regulations, corporate policies promoting drug-free environments, and the availability of advanced rapid testing kits and laboratory-based confirmation methods. Growing awareness of substance abuse impacts on workforce performance and safety is further encouraging adoption across both developed and emerging markets.

According to a national survey by American Addiction Centers, 15.3% of U.S. workers reported working under the influence of alcohol, while 2.9% admitted to being under the influence of illicit drugs in 2024. These figures underscore a significant challenge for U.S. employers, highlighting the need for strong workplace drug testing policies. Furthermore, there is a growing emphasis on workplace safety and productivity, prompting organizations to adopt measures that ensure a drug-free environment. Rising awareness of the adverse effects of substance misuse in the workplace, including reduced productivity, increased absenteeism, workplace accidents, and legal liabilities, further drives demand for drug testing services.

Global Employer And Workplace Drug Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global employer and workplace drug testing market on the basis of type, product, mode, drug, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Pre-employment drug screens
  • Post-employment
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services
  • Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Urine
  • Hair
  • Oral Fluid
  • Instant testing
  • Drug Outlook (Revenue, USD Million, 2021 - 2033)
  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • IT/Finance
  • Manufacturing
  • Transportation
  • Construction
  • Retail and Hospitality
  • Healthcare
  • Education
  • Other Professional Services
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Product Segment
    • 1.2.3. Mode Segment
    • 1.2.4. Drug Segment
    • 1.2.5. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global Employer and Workplace Drug Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for pre-employment testing
      • 3.2.1.2. Stringent laws mandating alcohol and drug testing in the workplace
      • 3.2.1.3. Rising prevalence of substance use in the workplace
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Changing legal environment and changing societal norms
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Technological advancement in drug testing for workplace
  • 3.3. Global Employer and Workplace Drug Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Global Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Employer and Workplace Drug Testing Market Type Movement Analysis
  • 4.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by type, 2021 to 2033 (USD Million)
  • 4.4. Pre-employment Drug Screens
    • 4.4.1. Pre-employment drug screens market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Post-employment
    • 4.5.1. Post-employment market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Employer and Workplace Drug Testing Market Product Movement Analysis
  • 5.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
  • 5.4. Consumables
    • 5.4.1. Consumables market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Instruments
    • 5.5.1. Instruments market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Rapid Testing Devices
    • 5.6.1. Rapid testing devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Services
    • 5.7.1. Services market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Global Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Employer and Workplace Drug Testing Market Mode Movement Analysis
  • 6.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by mode, 2021 to 2033 (USD Million)
  • 6.4. Urine
    • 6.4.1. Urine market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Hair
    • 6.5.1. Hair market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Oral Fluid
    • 6.6.1. Oral fluid market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Instant testing
    • 6.7.1. Instant testing market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Global Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Employer and Workplace Drug Testing Market Drug Movement Analysis
    • 7.2.1. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by drug, 2021 to 2033 (USD Million)
  • 7.3. Alcohol
    • 7.3.1. Alcohol market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4. Cannabis/Marijuana
    • 7.4.1. Cannabis/marijuana market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Cocaine
    • 7.5.1. Cocaine market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Opioids
    • 7.6.1. Opioids testing market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Amphetamine & Methamphetamine
    • 7.7.1. Amphetamine & methamphetamine market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. LSD
    • 7.8.1. LSD market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.9. Others
    • 7.9.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Global Employer and Workplace Drug Testing Market: End-use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Employer and Workplace Drug Testing Market End-use Movement Analysis
    • 8.2.1. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
  • 8.3. IT/Finance
    • 8.3.1. IT/finance market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.4. Manufacturing
    • 8.4.1. Manufacturing market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5. Transportation
    • 8.5.1. Transportation market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6. Construction
    • 8.6.1. Construction market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7. Retail and Hospitality
    • 8.7.1. Retail and hospitality market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8. Healthcare
    • 8.8.1. Healthcare market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.9. Education
    • 8.9.1. Education surgical centers market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.10. Other Professional Services
    • 8.10.1. Other Professional Services market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Employer and Workplace Drug Testing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework/ reimbursement structure
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework/ reimbursement structure
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework/ reimbursement structure
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework/ reimbursement structure
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework/ reimbursement structure
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.6. Norway
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework/ reimbursement structure
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework/ reimbursement structure
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.8. Denmark
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework/ reimbursement structure
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/ reimbursement structure
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework/ reimbursement structure
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework/ reimbursement structure
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Share Analysis, 2024
  • 10.4. List of Key Certification Providers/Scheme Owners
  • 10.5. Company Profiles/Listing
    • 10.5.1. First Advantage
      • 10.5.1.1. Company overview
      • 10.5.1.2. Financial performance
      • 10.5.1.3. Product benchmarking
      • 10.5.1.4. Strategic initiatives
    • 10.5.2. Laboratory Corporation of America Holdings (Labcorp)
      • 10.5.2.1. Company overview
      • 10.5.2.2. Financial performance
      • 10.5.2.3. Product benchmarking
      • 10.5.2.4. Strategic initiatives
    • 10.5.3. Dragerwerk AG & Co. KGaA
      • 10.5.3.1. Company overview
      • 10.5.3.2. Financial performance
      • 10.5.3.3. Product benchmarking
      • 10.5.3.4. Strategic initiatives
    • 10.5.4. Bio-Rad Laboratories, Inc.
      • 10.5.4.1. Company overview
      • 10.5.4.2. Financial performance
      • 10.5.4.3. Product benchmarking
      • 10.5.4.4. Strategic initiatives
    • 10.5.5. Abbott
      • 10.5.5.1. Company overview
      • 10.5.5.2. Financial performance
      • 10.5.5.3. Product benchmarking
      • 10.5.5.4. Strategic initiatives
    • 10.5.6. Clinical Reference Laboratory Inc.
      • 10.5.6.1. Company overview
      • 10.5.6.2. Financial performance
      • 10.5.6.3. Product benchmarking
      • 10.5.6.4. Strategic initiatives
    • 10.5.7. Quest Diagnostics
      • 10.5.7.1. Company overview
      • 10.5.7.2. Financial performance
      • 10.5.7.3. Product benchmarking
      • 10.5.7.4. Strategic initiatives
    • 10.5.8. Cordant Health Solutions
      • 10.5.8.1. Company overview
      • 10.5.8.2. Financial performance
      • 10.5.8.3. Product benchmarking
      • 10.5.8.4. Strategic initiatives
    • 10.5.9. DISA Global Solutions
      • 10.5.9.1. Company overview
      • 10.5.9.2. Financial performance
      • 10.5.9.3. Product benchmarking
      • 10.5.9.4. Strategic initiatives
    • 10.5.10. HireRight, LLC
      • 10.5.10.1. Company overview
      • 10.5.10.2. Financial performance
      • 10.5.10.3. Product benchmarking
      • 10.5.10.4. Strategic initiatives
    • 10.5.11. OraSure Technologies, Inc.
      • 10.5.11.1. Company overview
      • 10.5.11.2. Financial performance
      • 10.5.11.3. Product benchmarking
      • 10.5.11.4. Strategic initiatives
    • 10.5.12. Psychemedics Corporation
      • 10.5.12.1. Company overview
      • 10.5.12.2. Financial performance
      • 10.5.12.3. Product benchmarking
      • 10.5.12.4. Strategic initiatives
    • 10.5.13. Omega Laboratories
      • 10.5.13.1. Company overview
      • 10.5.13.2. Financial performance
      • 10.5.13.3. Product benchmarking
      • 10.5.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 U.S. employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 4 U.S. employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 5 U.S. employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 6 U.S. employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 7 U.S. employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 8 North America employer and workplace drug testing market, by region, 2021 - 2033 (USD Million)
  • Table 9 North America employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 10 North America employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 11 North America employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 12 North America employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 13 North America employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Canada employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 15 Canada employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 16 Canada employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 17 Canada employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 18 Canada employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Mexico employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 20 Mexico employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 21 Mexico employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 22 Mexico employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 23 Mexico employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Europe employer and workplace drug testing market, by region, 2021 - 2033 (USD Million)
  • Table 25 Europe employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 26 Europe employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 27 Europe employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 28 Europe employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 29 Europe employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 30 UK employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 31 UK employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 32 UK employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 33 UK employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 34 UK employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Germany employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 36 Germany employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 37 Germany employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 38 Germany employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 39 Germany employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 40 France employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 41 France employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 42 France employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 43 France employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 44 France employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Italy employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 46 Italy employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 47 Italy employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 48 Italy employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 49 Italy employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Spain employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 51 Spain employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 52 Spain employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 53 Spain employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 54 Spain employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Denmark employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 56 Denmark employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 57 Denmark employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 58 Denmark employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 59 Denmark employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 60 Sweden employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 61 Sweden employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 62 Sweden employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 63 Sweden employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 64 Sweden employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Norway employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 66 Norway employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 67 Norway employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 68 Norway employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 69 Norway employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Asia Pacific employer and workplace drug testing market, by region, 2021 - 2033 (USD Million)
  • Table 71 Asia Pacific employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 72 Asia Pacific employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 73 Asia Pacific employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 74 Asia Pacific employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 75 Asia Pacific employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Japan employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 77 Japan employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 78 Japan employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 79 Japan employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 80 Japan employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 81 China employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 82 China employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 83 China employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 84 China employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 85 China employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 86 India employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 87 India employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 88 India employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 89 India employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 90 India employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 91 Australia employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 92 Australia employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 93 Australia employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 94 Australia employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 95 Australia employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 96 South Korea employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 97 South Korea employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 98 South Korea employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 99 South Korea employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 100 South Korea employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 101 Thailand employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 102 Thailand employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 103 Thailand employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 104 Thailand employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 105 Thailand employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 106 Latin America employer and workplace drug testing market, by region, 2021 - 2033 (USD Million)
  • Table 107 Latin America employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 108 Latin America employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 109 Latin America employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 110 Latin America employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 111 Latin America employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 112 Brazil employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 113 Brazil employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 114 Brazil employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 115 Brazil employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 116 Brazil employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 117 Argentina employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 118 Argentina employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 119 Argentina employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 120 Argentina employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 121 Argentina employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 122 MEA employer and workplace drug testing market, by region, 2021 - 2033 (USD Million)
  • Table 123 MEA employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 124 MEA employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 125 MEA employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 126 MEA employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 127 MEA employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 128 South Africa employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 129 South Africa employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 130 South Africa employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 131 South Africa employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 132 South Africa employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 133 Saudi Arabia employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 134 Saudi Arabia employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 135 Saudi Arabia employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 136 Saudi Arabia employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 137 Saudi Arabia employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 138 UAE employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 139 UAE employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 140 UAE employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 141 UAE employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 142 global employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 143 Kuwait employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 144 Kuwait employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 145 Kuwait employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 146 Kuwait employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 147 Kuwait employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Global employer and workplace drug testing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Global employer and workplace drug testing market: Type outlook key takeaways
  • Fig. 20 Global employer and workplace drug testing market: Type movement analysis
  • Fig. 21 Pre-employment drug screens market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Post-employment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Global employer and workplace drug testing market: Product outlook key takeaways
  • Fig. 24 Global employer and workplace drug testing market: Product movement analysis
  • Fig. 25 Consumables market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Rapid testing devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Global employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 30 Global employer and workplace drug testing market: Mode movement analysis
  • Fig. 31 Urine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Hair market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Oral fluid market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Instant testing estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Global employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 36 Global employer and workplace drug testing market: Mode movement analysis
  • Fig. 37 Alcohol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Cannabis/marijuana market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Cocaine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Opioids estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Amphetamine & methamphetamine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 LSD market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Global employer and workplace drug testing market: End-use outlook key takeaways
  • Fig. 45 Global employer and workplace drug testing market: End-use movement analysis
  • Fig. 46 IT/finance market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Construction estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Retail and hospitality market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Education market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Other professional services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Employer and Workplace Drug Testing Market: Regional outlook and key takeaways
  • Fig. 55 Regional outlook, 2024 & 2033
  • Fig. 56 North America
  • Fig. 57 North America market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 U.S. key country dynamics
  • Fig. 59 U.S. market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Canada key country dynamics
  • Fig. 61 Canada market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Europe
  • Fig. 63 Europe market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 UK key country dynamics
  • Fig. 65 UK market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Germany
  • Fig. 67 Germany market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 France key country dynamics
  • Fig. 69 France market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Italy key country dynamics
  • Fig. 71 Italy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 Spain key country dynamics
  • Fig. 73 Spain market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Denmark key country dynamics
  • Fig. 75 Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 76 Sweden key country dynamics
  • Fig. 77 Sweden market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 78 Norway key country dynamics
  • Fig. 79 Norway market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 Asia-Pacific
  • Fig. 81 Asia-Pacific market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 82 Japan key country dynamics
  • Fig. 83 Japan market estimates and forecast, 2021 - 2033(USD Million)
  • Fig. 84 China key country dynamics
  • Fig. 85 China market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 86 India key country dynamics
  • Fig. 87 India market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 88 South Korea key country dynamics
  • Fig. 89 South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 90 Australia key country dynamics
  • Fig. 91 Australia market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 92 Thailand key country dynamics
  • Fig. 93 Thailand market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 94 Latin America
  • Fig. 95 Latin America market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 96 Brazil key country dynamics
  • Fig. 97 Brazil market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 98 Mexico key country dynamics
  • Fig. 99 Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 100 Argentina key country dynamics
  • Fig. 101 Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 102 Middle East & Africa
  • Fig. 103 MEA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 104 South Africa key country dynamics
  • Fig. 105 South Africa market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 106 Saudi Arabia key country dynamics
  • Fig. 107 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 108 UAE key country dynamics
  • Fig. 109 UAE market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 110 Kuwait key country dynamics
  • Fig. 111 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 112 Market differentiators
  • Fig. 113 Key company market share analysis, 2024